CPD Login
CPD Login
Last week, ATAGI announced vaccine recommendations for three respiratory conditions – influenza, COVID-19 and RSV.
Along with a change in season, pharmacists should gear up for a raft of changes set to take place on 1 March 2024.
Herpes Zoster (HZ), or shingles, is a common viral infection, with one in three people developing the condition in their lifetime.
Australia’s sun safety guidelines have been updated for diverse skin types to ensure maximum sun protection and vitamin D production.
Voluntary Assisted Dying (VAD) is now legal in most jurisdictions. But there’s a nation-wide regulation impeding access to the service.
A new PIMs list unveiled medicines that could result in negative clinical outcomes, including hospitalisation and death in older patients.
For those who were unable to make it to the PSA’s jam-packed NIPVIP webinar, here’s the most sought-after information from the expert hosts.
Australia should prepare now for a potential influx of synthetic opioids into the illicit drug market, an expert has told Australian Pharmacist, as overdoses increase internationally.
A worldwide Vyvanse, expected to last months, has left pharmacists inundated with requests for the popular ADHD medicine.
While the NIPVIP Program has been underway for almost a month, eligibility is still a murky area for many patients and pharmacists alike.